Tratamiento farmacológico de la hiperplasia prostática benigna. Revisión de la bibliografía

Abstract

Benign prostatic hyperplasia affects 50% of the population and is more frequent in the seventh and eighth decades of life. There are currently different treatments for benign prostatic hyperplasia and pharmacologic management is considered first-line trea